ID: ALA4461287

Max Phase: Preclinical

Molecular Formula: C15H10N2O3Se

Molecular Weight: 345.22

Molecule Type: Unknown

Representations

Canonical SMILES:  N#C[Se]c1ccc(NC(=O)c2ccccc2C(=O)O)cc1

Standard InChI:  InChI=1S/C15H10N2O3Se/c16-9-21-11-7-5-10(6-8-11)17-14(18)12-3-1-2-4-13(12)15(19)20/h1-8H,(H,17,18)(H,19,20)

Standard InChI Key:  HIXFKFODSKKXAV-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 345.22

Molecular Weight (Monoisotopic): 345.9857

AlogP:

#Rotatable Bonds:

Polar Surface Area:

Molecular Species:

HBA:

HBD:

#RO5 Violations:

HBA (Lipinski):

HBD (Lipinski):

#RO5 Violations (Lipinski):

CX Acidic pKa:

CX Basic pKa:

CX LogP:

CX LogD:

Aromatic Rings:

Heavy Atoms:

QED Weighted:

Np Likeness Score:

References

1. Garnica P, Encío I, Plano D, Palop JA, Sanmartín C..  (2019)  Organoseleno cytostatic derivatives: Autophagic cell death with AMPK and JNK activation.,  175  [PMID:31082766] [10.1016/j.ejmech.2019.04.074]

2. Garnica P,Etxebeste-Mitxeltorena M,Plano D,Moreno E,Espuelas S,Antonio Palop J,Jiménez-Ruiz A,Sanmartín C.  (2020)  Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.,  30  (17): [PMID:32738977] [10.1016/j.bmcl.2020.127371]

Source

Source(1):

• Scientific Literature